ALS / AMYOTROPHIC LATERAL SCLEROSIS

 

Marijuana in the management of amyotrophic lateral sclerosis       (abst – 2001)  http://ajh.sagepub.com/cgi/content/abstract/18/4/264?maxtoshow=&hits=80&RESULTFORMAT=&fulltex t=cannabis&searchid=1&FIRSTINDEX=1200&resourcetype=HWCIT

 

Survey of cannabis use in patients with amyotrophic lateral sclerosis.     (abst – 2004)

http://ajh.sagepub.com/cgi/content/abstract/21/2/95?maxtoshow=&hits=80&RESULTFORMAT=&fulltext

=cannabinoid&searchid=1&FIRSTINDEX=2000&resourcetype=HWCIT

 

Delayed disease progression in ALS mice by treatment with a cannabinoid.   (abst – 2004)

http://www.ncbi.nlm.nih.gov/pubmed/15204022?dopt=Abstract

 

Cannabis’ Potential Exciting Researchers in Treatment of ALS, Parkinson’s Disease – URB597                    (news – 2004)

http://www.illinoisnorml.org/index2.php?option=com_content&do_pdf=1&id=104

 

Cannabis Relieves Lou Gehrigs Symptoms – New Study      (news – 2004)

http://www.rense.com/general51/lou.htm

 

Marijuana-like compounds may aid array of debiliating conditions ranging from Parkinson’s to pain                                (news – 2004)

http://www.eurekalert.org/pub_releases/2004-10/sfn-mcm102604.php

 

Cannabinol delays symptom onset in SOD1 (G93A) transgenic mice without affecting survival.                       (abst – 2005)  http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=1618356 0

 

Increasing cannabinoid levels by pharmacological and genetic manipulation delay disease progression in SOD1 mice                                 (full – 2006)       http://www.fasebj.org/cgi/content/full/20/7/1003

 

AM1241, a cannabinoid CB2 receptor selective compound, delays disease progression in a mouse model of amyotrophic lateral sclerosis.                                       (abst – 2006)  http://www.ncbi.nlm.nih.gov/pubmed/16781706

 

The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset                                 (full – 2007)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2819701/?tool=pmcentrez

 

The endocannabinoid system in targeting inflammatory neurodegenerative diseases (full – 2007)

http://medicalcannabis.com/images/pdf09/indications/neurodegenerative/centonze_et_al_2007_inflammato  ry_neuro.pdf

 

Cannabinoids and neuroprotection in motor-related disorders.       (abst – 2007)

http://www.ncbi.nlm.nih.gov/pubmed/18220777

 

The (Endo)Cannabinoid System in Multiple Sclerosis and Amyotrophic Lateral Sclerosis (abst – 2007)                            http://www.ncbi.nlm.nih.gov/pubmed/17678961

 

The endocannabinoid system in amyotrophic lateral sclerosis.        (abst – 2008)

http://www.ncbi.nlm.nih.gov/pubmed/18781981

 

Altered presymptomatic AMPA and cannabinoid receptor trafficking in motor neurons of ALS model mice: implications for excitotoxicity.                                    (abst – 2008)  http://www.ncbi.nlm.nih.gov/pubmed/18279310

 

Role of CB2 receptors in neuroprotective effects of cannabinoids.     (abst – 2008)

http://www.ncbi.nlm.nih.gov/pubmed/18291574

 

Emerging Role of the CB2 Cannabinoid Receptor in Immune Regulation and Therapeutic Prospects                       (full – 2009)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768535/?tool=pmcentrez

 

Cannabinoids as Therapeutic Agents for Ablating Neuroinflammatory Disease (full – 2009)                         http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2750822/?tool=pmcentrez

 

Cannabinoids and neurodegenerative diseases.      (abst – 2009)

http://www.ncbi.nlm.nih.gov/pubmed/19839933

 

Medical Marijuana and Amyotrophic Lateral Sclerosis (ALS)         (news – 2009)

https://www.marijuanadoctors.com/content/ailments/view/92?ailment=amyotrophic-lateral-sclerosis-als-

 

Medical Marijuana and Lou Gehrig’s Disease         (news – 2009)

https://www.marijuanadoctors.com/content/ailments/view/91?ailment=lou-gehrig-s-disease

 

Cannabis and Amyotrophic Lateral Sclerosis: Hypothetical and Practical Applications, and a Call for Clinical Trials.                            (abst – 2010)      http://www.ncbi.nlm.nih.gov/pubmed/20439484

 

The endocannabinoid system in the inflammatory and neurodegenerative processes of multiple sclerosis and of amyotrophic lateral sclerosis.                       (abst – 2010)  http://www.ncbi.nlm.nih.gov/pubmed/20353778

 

Abnormal sensitivity of cannabinoid CB1 receptors in the striatum of mice with experimental amyotrophic lateral sclerosis.                              (abst – 2010)  http://www.ncbi.nlm.nih.gov/pubmed/19452308

 

The endocannabinoid system in gp120-mediated insults and HIV-associated dementia. (abst – 2010)                              http://www.ncbi.nlm.nih.gov/pubmed/20353779

 

Tetrahydrocannabinol (THC) for cramps in amyotrophic lateral sclerosis: a randomised, double-blind crossover trial.                               (abst – 2010)

http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=291

 

Marijuana May Extend Life Expectancy Of Lou Gehrig’s Disease Patients, Study Says (news – 2010)                               http://www.norml.org/index.cfm?Group_ID=8191

 

Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full – 2011)                               http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062638/

 

Single-dose Pharmacokinetics and Tolerability of Oral Delta-9-Tetrahydrocannabinol in Patients with Amyotrophic Lateral Sclerosis.                               (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22594565

 

Medical Cannabis Helps ALS Patient Outlive her Own Doctors (news/anecdotal – 2012)

http://www.examiner.com/article/medical-cannabis-helps-als-patient-outlive-her-own-doctors

 

 

 

Share a link for